Skip navigation

AstraZeneca PLC

Pharmaceuticals
United Kingdom
2016 Revenue (US$ Millions)$23,002
Revenue Growth (%)-6.90%
Net Income (US$ Millions)$3,499
Earnings Per Share (US$)$2.76
EPS Growth Rate (%)23.77%
Profit Margin15.21%
Total Equity (US$ Millions)$14,854
Return on Equity (%)18.92%
Long Term Debt (US$ Millions)$14,501
Debt To Equity Ratio (%)0.98%
Total Assets (US$ Millions)$62,526
Current Assets (US$ Millions)$13,262
Current Liabilities (US$ Millions)$15,256
Cost of Goods Sold (US$ Millions)$4,126
Inventory Turnover1.84